[1]
|
Yuan, J., Amin, P. and Ofengeim, D. (2019) Necroptosis and RIPK1-Mediated Neuroinflammation in CNS Diseases. Nature Reviews Neuroscience, 20, 19-33. https://doi.org/10.1038/s41583-018-0093-1
|
[2]
|
Li, W., Shan, B., Zou, C., et al. (2022) Nuclear RIPK1 Promotes Chromatin Remodeling to Mediate Inflammatory Response. Cell Research, 32, 621-637. https://doi.org/10.1038/s41422-022-00673-3
|
[3]
|
Mifflin, L., Hu, Z., Dufort, C., et al. (2021) A RIPK1-Regulated Inflammatory Microglial State in Amyotrophic Lateral Sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 118, e2025102118.
https://doi.org/10.1073/pnas.2025102118
|
[4]
|
Degterev, A., Ofengeim, D. and Yuan, J. (2019) Targeting RIPK1 for the Treatment of Human Diseases. Proceedings of the National Academy of Sciences of the United States of America, 116, 9714-9722.
https://doi.org/10.1073/pnas.1901179116
|
[5]
|
Najjar, M., Saleh, D., Zelic, M., et al. (2016) RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-Like Receptor 4. Immunity, 45, 46-59. https://doi.org/10.1016/j.immuni.2016.06.007
|
[6]
|
Ito, Y., Ofengeim, D., Najafov, A., et al. (2016) RIPK1 Medi-ates Axonal Degeneration by Promoting Inflammation and Necroptosis in ALS. Science, 353, 603-608. https://doi.org/10.1126/science.aaf6803
|
[7]
|
Varfolomeev, E. and Vucic, D. (2018) Intracellular Regulation of TNF Activity in Health and Disease. Cytokine, 101, 26-32. https://doi.org/10.1016/j.cyto.2016.08.035
|
[8]
|
Chen, Z.J. (2012) Ubiquitination in Signaling to and Activation of IKK. Immunological Reviews, 246, 95-106.
https://doi.org/10.1111/j.1600-065X.2012.01108.x
|
[9]
|
Shan, B., Pan, H., Najafov, A., et al. (2018) Necroptosis in Development and Diseases. Genes & Development, 32, 327-340. https://doi.org/10.1101/gad.312561.118
|
[10]
|
Micheau, O. and Tschopp, J. (2003) Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes. Cell, 114, 181-190. https://doi.org/10.1016/S0092-8674(03)00521-X
|
[11]
|
Bertrand, M.J., Milutinovic, S., Dickson, K.M., et al. (2008) cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases That Promote RIP1 Ubiquitination. Molecular Cell, 30, 689-700.
https://doi.org/10.1016/j.molcel.2008.05.014
|
[12]
|
Wei, R., Xu, L.W., Liu, J., et al. (2017) SPATA2 Regulates the Activation of RIPK1 by Modulating Linear Ubiquitination. Genes & Development, 31, 1162-1176. https://doi.org/10.1101/gad.299776.117
|
[13]
|
Kanayama, A., Seth, R.B., Sun, L., et al. (2004) TAB2 and TAB3 Activate the NF-kappaB Pathway through Binding to Polyubiquitin Chains. Molecular Cell, 15, 535-548. https://doi.org/10.1016/j.molcel.2004.08.008
|
[14]
|
Geng, J., Ito, Y., Shi, L., et al. (2017) Regulation of RIPK1 Activation by TAK1-Mediated Phosphorylation Dictates Apoptosis and Necroptosis. Nature Communications, 8, 359. https://doi.org/10.1038/s41467-017-00406-w
|
[15]
|
Jaco, I., Annibaldi, A., Lalaoui, N., et al. (2017) MK2 Phos-phorylates RIPK1 to Prevent TNF-Induced Cell Death. Molecular Cell, 66, 698-710. https://doi.org/10.1016/j.molcel.2017.05.003
|
[16]
|
Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., et al. (2015) NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. Molecular Cell, 60, 63-76.
https://doi.org/10.1016/j.molcel.2015.07.032
|
[17]
|
Wang, X., Kuang, N., Chen, Y., et al. (2021) Transplantation of Olfactory Ensheathing Cells Promotes the Therapeutic Effect of Neural Stem Cells on Spinal Cord Injury by Inhibiting Necrioptosis. Aging (Albany NY), 13, 9056-9070.
https://doi.org/10.18632/aging.202758
|
[18]
|
Gerlach, B., Cordier, S.M., Schmukle, A.C., et al. (2011) Linear Ubiquitination Prevents Inflammation and Regulates Immune Signalling. Nature, 471, 591-596. https://doi.org/10.1038/nature09816
|
[19]
|
Ikeda, F., Deribe, Y.L., Skånland, S.S., et al. (2011) SHARPIN Forms a Linear Ubiquitin Ligase Complex Regulating NF-κB Activity and Apoptosis. Nature, 471, 637-641. https://doi.org/10.1038/nature09814
|
[20]
|
Haas, T.L., Emmerich, C.H., Gerlach, B., et al. (2009) Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction. Molecular Cell, 36, 831-844. https://doi.org/10.1016/j.molcel.2009.10.013
|
[21]
|
Elliott, P.R., Leske, D., Hrdinka, M., et al. (2016) SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. Molecular Cell, 63, 990-1005. https://doi.org/10.1016/j.molcel.2016.08.001
|
[22]
|
Rahighi, S., Ikeda, F., Kawasaki, M., et al. (2009) Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-kappaB Activation. Cell, 136, 1098-1109. https://doi.org/10.1016/j.cell.2009.03.007
|
[23]
|
Hadian, K., Griesbach, R.A., Dornauer, S., et al. (2011) NF-κB Essential Modulator (NEMO) Interaction with Linear and lys-63 Ubiquitin Chains Contributes to NF-κB Activation. Journal of Biological Chemistry, 286, 26107-26117.
https://doi.org/10.1074/jbc.M111.233163
|
[24]
|
Nanda, S.K., Venigalla, R.K., Ordureau, A., et al. (2011) Polyubiquitin Binding to ABIN1 Is Required to Prevent Autoimmunity. Journal of Experimental Medicine, 208, 1215-1228. https://doi.org/10.1084/jem.20102177
|
[25]
|
Xu, D., Jin, T., Zhu, H., et al. (2018) TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. Cell, 174, 1477-1491. https://doi.org/10.1016/j.cell.2018.07.041
|
[26]
|
Zhu, K., Liang, W., Ma, Z., et al. (2018) Necroptosis Promotes Cell-Autonomous Activation of Proinflammatory Cytokine gene Expression. Cell Death & Disease, 9, 500. https://doi.org/10.1038/s41419-018-0524-y
|
[27]
|
Christofferson, D.E., Li, Y., Hitomi, J., et al. (2012) A Novel Role for RIP1 Kinase in Mediating TNFα Production. Cell Death & Disease, 3, e320. https://doi.org/10.1038/cddis.2012.64
|
[28]
|
McNamara, C.R., Ahuja, R., Osafo-Addo, A.D., et al. (2013) Akt Regulates TNFα Synthesis Downstream of RIP1 Kinase Activation during Necroptosis. PLOS ONE, 8, e56576. https://doi.org/10.1371/journal.pone.0056576
|
[29]
|
Saleh, D., Najjar, M., Zelic, M., et al. (2017) Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide. The Journal of Immunology, 198, 4435-4447. https://doi.org/10.4049/jimmunol.1601717
|
[30]
|
Feldman, E.L., Goutman, S.A., Petri, S., et al. (2022) Amyotrophic Lateral Sclerosis. The Lancet, 400, 1363-1380.
https://doi.org/10.1016/S0140-6736(22)01272-7
|
[31]
|
Lafont, E., Draber, P., Rieser, E., et al. (2018) TBK1 and IKKε Prevent TNF-Induced Cell Death by RIPK1 Phosphorylation. Nature Cell Biology, 20, 1389-1399. https://doi.org/10.1038/s41556-018-0229-6
|
[32]
|
Weisel, K., Scott, N., Berger, S., et al. (2021) A Randomised, Placebo-Controlled Study of RIPK1 Inhibitor GSK2982772 in Patients with Active Ulcerative Colitis. BMJ Open Gas-troenterology, 8, e000680.
https://doi.org/10.1136/bmjgast-2021-000680
|
[33]
|
Weisel, K., Berger, S., Thorn, K., et al. (2021) A Randomized, Placebo-Controlled Experimental Medicine Study of RIPK1 Inhibitor GSK2982772 in Patients with Moderate to Severe Rheumatoid Arthritis. Arthritis Research & Therapy, 23, 85. https://doi.org/10.1186/s13075-021-02468-0
|
[34]
|
Weisel, K., Scott, N.E., Tompson, D.J., et al. (2017) Random-ized Clinical Study of Safety, Pharmacokinetics, and Pharmacodynamics of RIPK1 Inhibitor GSK2982772 in Healthy Volunteers. Pharmacology Research & Perspectives, 5, e00365. https://doi.org/10.1002/prp2.365
|
[35]
|
Vissers, M., Heuberger, J., Groeneveld, G.J., et al. (2022) Safety, Pharmacokinetics and Target Engagement of Novel RIPK1 Inhibitor SAR443060 (DNL747) for Neurodegenerative Disorders: Randomized, Placebo-Controlled, Double-Blind Phase I/Ib Studies in Healthy Subjects and Patients. Clinical and Translational Science, 15, 2010-2023.
https://doi.org/10.1111/cts.13317
|
[36]
|
Wang, T., Perera, N.D., Chiam, M., et al. (2020) Necroptosis Is Dispensable for Motor Neuron Degeneration in a Mouse Model of ALS. Cell Death & Differentiation, 27, 1728-1739. https://doi.org/10.1038/s41418-019-0457-8
|
[37]
|
Dominguez, S., Varfolomeev, E., Brendza, R., et al. (2021) Ge-netic Inactivation of RIP1 Kinase Does Not Ameliorate Disease in a Mouse Model of ALS. Cell Death & Differentiation, 28, 915-931.
https://doi.org/10.1038/s41418-020-00625-7
|